SAR and biological evaluation of novel trans-3,4-dimethyl-4-arylpiperidine derivatives as opioid antagonists.
Díaz N, Benvenga M, Emmerson P, Favors R, Mangold M, McKinzie J, Patel N, Peters S, Quimby S, Shannon H, Siegel M, Statnick M, Thomas E, Woodland J, Surface P, Mitch C.
Díaz N, et al.
Bioorg Med Chem Lett. 2005 Sep 1;15(17):3844-8. doi: 10.1016/j.bmcl.2005.05.123.
Bioorg Med Chem Lett. 2005.
PMID: 15993591